Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Thymalfasin
Add to protocol
Build with Thymosin Alpha-1
Compare prices
Pharmacies & vendors
Calculate dosing
Reconstitution
Thymosin Alpha-1 is a thymic peptide that plays a key role in immune system maturation and function. It is approved in several countries for treatment of hepatitis B and C, and as an immune adjuvant.
Thymosin Alpha-1 enhances T-cell function, promotes dendritic cell maturation, and modulates cytokine production. It activates both innate and adaptive immune responses.
Approved in over 35 countries (marketed as Zadaxin) for hepatitis B and as an immune adjuvant. Clinical trials show improved immune responses in hepatitis, cancer immunotherapy, and vaccine adjuvancy. It gained renewed interest during COVID-19 for its ability to restore immune competence in lymphopenic patients.
Typical Dose
1.6mg
Range
1.6-3.2mg
Frequency
2x/week (subcutaneous)
Route
SubQ
Duration
4-8 weeks
Reconstitution
5mg vial + 1mL bacteriostatic water = 5,000mcg/mL
Notes
Standard clinical dose is 1.6 mg SubQ two to three times weekly. Some protocols use daily dosing during acute infections. Cycles of 2–6 months are common in clinical settings.
These biomarkers are commonly tracked to assess response and safety. Run baseline labs before starting, mid-cycle labs halfway through, and post-cycle labs 1–2 weeks after the final dose.
Build a protocol with Thymosin Alpha-1, schedule blood work for key biomarkers, and track your results.
Build Protocol with Thymosin Alpha-1This platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.
Disclosed Labs